Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer

Brain, Behavior, and Immunity

Volumn 30, Issue SUPPL., 2013, Pages

  Antoni, Michael H ^a  

^a Department of Biology   (United States)

Author keywords

Biobehavioral processes; Cancer; Psychosocial intervention; Recurrence; Stress management; Survival

Indexed keywords

ADAPTATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; DISEASE COURSE; HUMAN; INTERVENTION STUDY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; STRESS;

ADAPTATION, PSYCHOLOGICAL; BEHAVIOR THERAPY; DISEASE PROGRESSION; HUMANS; INFLAMMATION; NEOPLASMS; STRESS, PSYCHOLOGICAL;

EID: 84875368001     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.05.009     Document Type: Review

References (94)

1. Andersen B.L., Kiecolt-Glaser J.K., Glaser R. A biobehavioral model of cancer stress and disease course. Am. Psychol. 1994, 49:389-404.
2. Andersen B., Farrar W.B., Golden-Kreutz D.M., Glaser R., Emery C.F., Crespin T.R., et al. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol. 2004, 22:3570-3580.
3. Andersen B.L., Farrar W.B., Golden-Kreutz D., et al. Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav. Immun. 2007, 21:953-961.
4. Andersen B., Shelby R., Golden-Kruetz D. RCT of a psychological intervention for persons with cancer. I. Mechanisms of change. J. Consult. Clin. Psychol. 2007, 75:927-938.
5. Andersen B.L., Yang H.C., Farrar W.B., et al. Psychologic intervention improves survival for breast cancer patients: A randomized clinical trial. Cancer 2008, 113:3450-3458.
6. Andersen B.L., Thornton L., Shapiro C., Farrar W., Mundy B., Yang H., Carson W. Biobehavioral, immune and health benefits following recurrence for psychological intervention participants. Clin. Cancer Res. 2010, 16:3270-3278.
7. Antoni M.H. Stress Management Intervention for Women With Breast Cancer 2003, American Psychological Association Press, Washington D.C.
8. Antoni M.H., Schneiderman N., Penedo F. Behavioral interventions: Immunologic mediators and disease outcomes. Psychoneuroimmunology 2006, 675-703. Academic, NY. fourth Ed. R. Ader, R. Glaser, N. Cohen, M. Irwin (Eds.).
9. Antoni M.H., Lutgendorf S., Cole S., Dhabhar F., Sephton S., McDonald P., Stefanek M., Sood A. The influence of biobehavioral factors on tumor biology: pathways and mechanisms. Nat. Rev. Cancer 2006, 6:240-248.
10. Antoni M.H., Lechner S.C., Kazi A., Wimberly S., Gluck S., Carver C.S. How stress management improves quality of life after breast cancer treatment. J. Consult. Clin. Pyschol. 2006, 74:1143-1152.
11. Antoni M.H., Wimberly S.R., Lechner S.C., Kazi A., Sifre T., Urcuyo K.R., Phillips K., Smith R.G., Petronis V.M., Guellati S., Wells K.A., Blomberg B., Carver C.S. Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. Am. J. Psychiatry 2006, 163(10):1791-1797.
12. Antoni M.H., Pereira D.B., Marion I., Ennis N., Andrasik M.P., Rose R., et al. Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women. J. Psychosom. Res. 2008, 65:389-401.
13. Antoni M.H., Lechner S., Diaz A., Vargas S., Holley H., Phillips K., McGregor B.A., Carver C.S., Blomberg B. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav. Immun. 2009, 23:159-166.
14. Antoni M.H., Lutgendorf S., Blomberg B., Carver C.S., Lechner S., Diaz A., Stagl J., Arevalo J., Cole S. Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics. Biol. Psychiatry 2012, 71:366-372.
15. Basaria S., Muller D.C., Carducci M.A., Egan J., Dobs A.S. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006, 106:581-588.
16. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 2003, 17:S27-S38.
17. Benish M., Ben-Eliyahu S. Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses. Cancers 2010, 2:1929-1951.
18. Biganzoli E., Boracchi P. Old and new markers for breast cancer prognosis: the need for integrated research on quantitative issues. Eur. J. Cancer 2004, 40:1803-1806.
19. Bloom J.R., Petersen D., Kang S.H. Multidimensional quality of life among long-term adult cancer survivors. Psycho-Oncol. 2007, 16:691-706. 10.1002/pon.1208.
20. Bovjberg D. Psychoneuroimmunology: implications for oncology?. Cancer 1991, 67:828-832.
21. Brothers B.M., Andersen B.L. Hopelessness as a predictor of depressive symptoms for breast cancer patients coping with recurrence. Psycho-Oncology 2009, 18:267-275.
22. Carlson L.E., Speca M., Faris P., Patel K.D. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav. Immun. 2007, 21(8):1038-1049.
23. Carrico A., Antoni M.H. The effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials. Psychosom. Med. 2008, 70:575-584.
24. Carver C.S., Smith R.G., Antoni M.H., Petronis V.M., Weiss S., Derhagopian R.P. Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psychol. 2005, 24:508-516.
25. Chrousos G. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int. J. Obes. Relat. Metab. Disord. 2000, 24:S550-S555.
26. Cohen L., Parker O., Vence L., Savary C., Kentor D., Pettaway C., Babaian R., Pisters L., Miles B., Wei Q., Wiltz L., Patel T., Radvanyi L. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom. Med. 2011, 73:218-225.
27. Cole S.W. Social regulation of human gene expression. Curr. Dir. Psychol. Sci. 2009, 18:132-137.
28. Cole S.W. Chronic inflammation and breast cancer recurrence. J. Clin. Oncol. 2009, 27:3418-3419.
29. Cole S.W., Hawkley L.C., Arevalo J.M., Cacioppo J.T. Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proc. Natl. Acad. Sci. USA 2011, 108:3080-3085.
30. Cordova M.J., Andrykowski M.A., Kenady D.E., McGrath P.C., Sloan D.A., Redd W.H. Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J. Consult. Clin. Psychology. 1995, 63:981-986.
31. Disis M.L., Lyerly H.K. Global role of the immune system in identifying cancer initiation and limiting disease progression. J. Clin. Oncol. 2005, 23(35):8923-8925.
32. Dowling R., Goodwin P., Stambolic V. Understanding the benefit of metformin use in cancer treatment. PMC Med. 2011, 9:33.
33. Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry 2010, 68:748-754.
34. Fawzy F.I., Cousins N., Fawzy N.W., Kemeny M.E., Elashoff R., Morton D. A structured psychiatric intervention for cancer patients, I: changes over time in methods of coping and affective disturbance. Arch. Gen. Psychiatry 1990, 47:720-725.
35. Fawzy F.I., Kemeny M.E., Fawzym N.W., Elashoff R., Morton D., Cousins N., Fahey J.L. A structured psychiatric intervention for cancer patients, II: changes over time in immunological measures. Arch. Gen. Psychiatry 1990, 47:729-735.
36. Fawzy F.I., Fawzy N.W., Hyun C.S., Elashoff R., Guthrie D., Fahey J.L., Morton D.L. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6years later. Arch. Gen. Psychiatry 1993, 50:681-689.
37. Fawzy F., Canada A., Fawzy S. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch. Gen. Psychiatry 2003, 60:100-103.
38. Figueiredo M.I., Fries E., Ingram K.M. The role of disclosure patterns and unsupportive social interactions in the well-being of breast cancer patients. Psycho-oncology 2004, 13:96-105.
39. Friedman L.C., Kalidas M., Elledge R., Chang J., Romero C., Husain I., et al. Optimism, social support, and psychosocial functioning among women with breast cancer. Psycho-Oncology 2005, 15:595-603.
40. Ganz P., Desmond K., Leedham B., Rowland J., Meyerowitz B., Belin T. Quality of life in long-term. Disease-free survivors of breast cancer: a Follow-up study. J. Natl. Cancer Inst. 2002, 94:39-49.
41. Giese-Davis J., Collie K., Rancourt K.M., et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J. Clin. Oncol. 2011, 29:413-420.
42. Goodwin P.J., Leszcz M., Ennis M. The effect of group psychosocial support on survival in metastatic breast cancer. N. Engl. J. Med. 2001, 345:1719-1726.
43. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
44. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 2009, 66:407-414.
45. Heckman T.G., Barcikowski R., Ogles B., Suhr J., Carlson B., Holroyd K., Garske J. A telephone-delivered coping improvement group intervention for middle-aged and older adults living with HIV/AIDS. Ann. Behav. Med. 2006, 32:27-38.
46. Hinnen C., Ranchor A., Sandeman R., Snijders T., Hagedoom M., Coyne J. Course of distress in breast cancer patients, their partners, and matched control couples. Ann. Behav. Med. 2008, 36:141-148.
47. Hoffman K., Derdak J., Bernstein D., Reynolds J., Avila N., Gerber L., Steinberg S., Chrousos G., Mackall C., Mansky P. Metabolic syndrome traits in long-term survivors of pediatric sarcoma. Pediatr. Blood Cancer 2008, 50:341-346.
48. Jacobsen P. Screening of psychological distress in cancer patients: challenges and opportunities. J. Clin. Oncol. 2007, 25:4526-4527.
49. Kissane D., Grabsch B., Clarke D. Supportive-expressive group therapy for women with metastatic breast cancer: Survival and psychosocial outcomes from a randomized controlled trial. Psycho-Oncol. 2007, 16:277-286.
50. Kuchler T., Bestmann B., Rappat S., et al. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J. Clin. Oncol. 2007, 25:2702-2708.
51. Luebbert K., Dahme B., Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 2001, 10:490-502.
52. Lutgendorf S.K., Sood A. Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Invited review Psychosomatic Medicine 2011, 73:724-730.
53. Lutgendorf S.K., Degeest K., Sung C.Y., Arevalo J.M., Penedo F., Lucci J., et al. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav. Immun. 2009, 23:176-183.
54. Lutgendorf S.K., Sood A., Antoni M.H. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J. Clin. Oncol. 2010, 28:4094-4099.
55. Lutgendorf S.K., Mullen-Houser E., Russell D., DeGeest K., Jacobsen G., Hart L., Bender D., Buekers T., Goodheart M., Antoni M.H., Sood A., Lubaroff D. Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. Brain Behav. Immun. 2010, 24:1231-1240.
56. McGregor B., Antoni M.H. Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav. Immun. 2009, 23:159-166.
57. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21:531-541.
58. Miller G.E., Chen E., Sze J., Marin T., Arevalo J.M., Doll R., et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol. Psychiatry 2008, 64:266-272.
59. Miller G.E., Chen E., Fok A.K., Walker H., Lim A., Nicholls E.F., et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl. Acad. Sci. USA 2009, 106:14716-14721.
60. Miller S., Bowen D., Croyle R., Rowland J. Overview, current status, and future directions. Handbook of Cancer Control and Behavioral Science 2009, 3-22. American Psychological Association, Washington, DC. S. Miller, D. Bowen, R. Croyle, J. Rowland (Eds.).
61. Nausheen B., Gidron Y., Peveler R., Moss-Morris R. Social support and cancer progression: a systematic review. J. Psychosom. Res. 2009, 67:403-415.
62. Nelson E., Wenzel L., Osann K., Dogan-Ates A., Chatana N., Reina-Patton A., Laust A., Nashimoto K., Chicz-DeMet A., DuPont N., Monk B. Stress, immunity and cervical cancer: biobehavioral outcomes of a randomized clinical trial. Clin. Cancer Res. 2008, 14(27):2111-2118.
63. Newell S., Sanson-Fisher R., Savolainen N. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J. NCI 2002, 94:558-584.
64. Pall S.K., Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J. Clin. Oncol. 2010, 28:4086-4093.
65. Patnaik J.L., Byers T., DiGuiseppi C., Denberg T.D., Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J. NCI 2011, 103:1101-1111.
66. Phillips K.M., Antoni M.H., Lechner S.C., Blomberg B.B., Llabre M., Avisar E., Gluck S., Dehragopian R., Carver C. Stress management intervention reduces serum cortisol and increases relaxation during treatment for non-metastatic breast cancer. Psychosom. Med. 2008, 70:1044-1049.
67. Phillips K.M., Antoni M.H., Carver C.S., Lechner S.C., Penedo F.J., McCullough M.E., Glück S., DerHagopian R., Blomberg B.B. Stress management skills and reductions in serum cortisol across the year after surgery for non-metastatic breast cancer. Cogn. Ther. Res. 2011, 35:595-600.
68. Pierce B.L., Ballard-Barbash R., Bernstein L., Baumgartner R.N., Neuhouser M.L., Wener M.H., et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol. 2009, 27:3437-3444.
69. Pinquart M., Duberstein P. Associations of social networks with cancer mortality: a meta-analysis. Crit. Rev. Oncol. Hematol. 2010, 75:122-137.
70. Savard J., Simard S., Ivers H., Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J. Clin. Oncol. 2005, 23:6097-6106.
71. Schmidt M., Chang-Claude J., Vrieling A., Heinz J., Flesch-Janys D., Steindorf K. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern. J. Cancer Survivorship 2012, 6:11-19.
72. Schneiderman N., Antoni M.H., Penedo F., Ironson G. Psychosocial and behavioral interventions in the treatment of physical illnesses and disease processes. Handbook of Behavioral Medicine: Methods and Applications 2010, 989-1007. Springer, NY. A. Steptoe (Ed.).
73. Sephton S., Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?. Brain Behav. Immun. 2003, 17:321-328.
74. Sephton S., Sapolsky R.M., Kraemer H.C., Spiegel D. Early mortality in metastatic breast cancer patients with absent of abnormal diurnal cortisol rhythms. J. Nat. Cancer Inst. 2000, 92:994-1000.
75. Sestak I., Distler W., Forbes J.F., et al. Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: An exploratory analysis from the ATAC trial. J. Clin. Oncol. 2010, 28:3411-3415.
76. Spencer S., Lehman J., Wynings C., Arena P., Carver C.S., Antoni M.H., Derhagopian R., Ironson G., Love N. Concerns about breast cancer and relations to psychosocial well-being in a multi-ethnic sample of early stage patients. Health Psychol. 1999, 18:159-169.
77. Spiegel D. Mind matters in cancer survival. JAMA 2011, 305:502-503.
78. Spiegel D., Bloom J.R., Kraemer H.C., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 2:888-891.
79. Spiegel D., Butler L.D., Giese-Davis J., Koopman C., Miller E., DiMiceli S., et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 2007, 110:1130.
80. Stanton A.L. Psychosocial concerns and interventions for cancer survivors. J. Clin. Oncol. 2006, 24:5132-5173.
81. Stark J., Avitsur R., Padgett D.A., Sheridan J.F. Social stress induces glucocorticoid resistance in macrophages. American J. Physiol. Reg. Int. Comp Physiol. 2001, 280:R1799-R1805.
82. Steginga S., Lynch B., Hawkes A., Dunn J., Aitken J. Antecedents of domain-specific quality of life after colorectal cancer. Psychooncology 2009, 18:216-220.
83. Stein K., Syrjala K., Andrykowski M. Physical and psychological long-term and late effects of cancer. Cancer 2008, 112:2577-2592.
84. Talley A., Molix L., Schlegel R.J., Bettencourt A. The influence of breast cancer survivors' perceived partner social support and need satisfaction on depressive symptoms: a longitudinal analysis. Psychol. Health 2010, 25:433-449.
85. Temel J.S., Greer J.A., Muzikansky A., et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N. Engl. J. Med. 2010, 363:733-742.
86. Thomson C., Thompson P.A., Wright-Bea J., Nardi E., Frey G.R., Stopeck A. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J. Women's Health 2009, 18:2041-2047.
87. Thornton L., Andersen B., Carson W. Immune, endocrine, and behavioral precursors to breast cancer recurrence. a case-control analysis. Cancer Immunol. Immunother. 2008, 57:1471-1481.
88. Thornton L., Andersen B., Scholer T., Carson W. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom. Med. 2009, 71:715-724.
89. van der Pompe G., Antoni M.H., Heijen C. The effects of surgical stress and psychological stress on the immune function of operative cancer patients. Psychol. Health 1998, 13:1015-1026.
90. Vitaliano P., Scanlon J., Zhang J., Savage M., Hirsch I., Siegler I. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosomatic Med. 2002, 64:418-435.
91. Wenzel L., DeAlba I., Habbal R., Kluhsman B., Fairclough D., Krebs L., Anton-Culver H., Berkowitz R., Aziz N. Quality of life in long-term cervical cancer survivors. Gynecol. Oncol. 2005, 97:310-317.
92. Wimberly S.R., Carver C.S., Laurenceau J.P., Harris S.D., Antoni M.H. Perceived partner reactions to diagnosis and treatment of breast cancer: impact on psychosocial and psychosexual adjustment. J. Consult. Clin. Psychol. 2005, 73:300-311.
93. Witek-Janusek L., Albuquerque K., Chroniak K.R., Chroniak C., Durazo-Arvizu R., Mathews H. Effect of mindfulness-based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav. Immun. 2008, 22:969-981.
94. Woodward W.A., Storm E.A., Tucker S.L., McNeese M.D. Changes in the 2003 AJCC staging for breast cancer dramatically affect stage specific survival. J. Clin. Oncol. 2003, 21:3244-3248.